Debt to Equity Ratio Chart

View Debt to Equity Ratio for USPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 0.7737
December 31, 2025 0.6615
September 30, 2025 0.6124
June 30, 2025 0.6099
March 31, 2025 0.618
December 31, 2024 0.6038
September 30, 2024 0.5269
June 30, 2024 0.5344
March 31, 2024 0.5343
December 31, 2023 0.543
September 30, 2023 0.5293
June 30, 2023 0.5347
March 31, 2023 0.9417
December 31, 2022 0.9352
September 30, 2022 0.8312
June 30, 2022 0.8579
March 31, 2022 0.75
December 31, 2021 0.7546
September 30, 2021 0.4705
June 30, 2021 0.4741
March 31, 2021 0.4019
December 31, 2020 0.4019
September 30, 2020 0.3758
June 30, 2020 0.506
March 31, 2020 0.8659
Date Value
December 31, 2019 0.5737
September 30, 2019 0.597
June 30, 2019 0.638
March 31, 2019 0.5149
December 31, 2018 0.1845
September 30, 2018 0.2805
June 30, 2018 0.2903
March 31, 2018 0.2324
December 31, 2017 0.2966
September 30, 2017 0.3159
June 30, 2017 0.3886
March 31, 2017 0.3347
December 31, 2016 0.2763
September 30, 2016 0.2323
June 30, 2016 0.2765
March 31, 2016 0.3489
December 31, 2015 0.2871
September 30, 2015 0.3089
June 30, 2015 0.276
March 31, 2015 0.2859
December 31, 2014 0.2435
September 30, 2014 0.3374
June 30, 2014 0.3386
March 31, 2014 0.3569
December 31, 2013 0.3233

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Acadia Healthcare Co., Inc. 1.363
DaVita, Inc. -17.50
Progyny, Inc. 0.0621
Lifestance Health Group, Inc. 0.3227
Quest Diagnostics, Inc. 0.8697